Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials (Q43283710)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2009

Language	Label	Description	Also known as
English	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials	scientific article published in August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Leonardo M. Fabbri

object named as

Leonardo M Fabbri

1

0 references

Fernando J Martinez

6

object named as

Fernando J Martinez

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

7

object named as

Klaus F Rabe

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Peter M A Calverley

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

José Luis Izquierdo-Alonso

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Daniela S Bundschuh

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Manja Brose

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

M2-127 and M2-128 study groups

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

language of work or name

0 references

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

374

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

9691

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

695-703

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

COPD: what is the unmet need?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol plus theophylline combination therapy in the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging pharmacotherapies for COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PDE4 inhibitors: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic inflammation and mortality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Are phosphodiesterase 4 inhibitors just more theophylline?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961252-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61252-6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43283710&oldid=2250882226"